Literature DB >> 29126048

Lennox-Gastaut syndrome in adulthood: Long-term clinical follow-up of 38 patients and analysis of their recorded seizures.

Aglaia Vignoli1, Gaia Oggioni2, Giovanni De Maria3, Angela Peron4, Miriam Nella Savini2, Elena Zambrelli2, Valentina Chiesa2, Francesca La Briola2, Katherine Turner2, Maria Paola Canevini1.   

Abstract

Lennox-Gastaut syndrome (LGS) is a severe epileptic encephalopathy with childhood onset that usually continues through adolescence and into adulthood. In the long term, patients with this condition still have intractable seizures, intellectual disability, behavioral problems, and physical comorbidities. The aim of this study was to describe the clinical and EEG characteristics of a group of adults with Lennox-Gastaut syndrome. We identified 38 (22 females, 16 males) patients with LGS older than age 18years at their last evaluation, with mean age of 43.3±10.6years. Median follow-up was 14.4years (range: 2-40). All of our patients had 3 or more seizure types during their clinical history. The most prevalent seizure types at follow-up were atypical absences (28/38), tonic (28/38), generalized tonic-clonic (17/38), focal (11/38), and myoclonic seizures (9/38). All patients had drug-resistant seizures. Besides epilepsy, intellectual disability and behavioral problems were prominent features. Surprisingly, paroxysmal nonepileptic seizures were reported in 3 patients. Our observations confirm the poor outcome of Lennox-Gastaut syndrome through adulthood, regardless of age at seizure onset, etiology, and history of previous West syndrome.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug-resistance; Lennox–Gastaut syndrome; Long-term evolution; Seizures; Video-EEG recordings

Mesh:

Year:  2017        PMID: 29126048     DOI: 10.1016/j.yebeh.2017.09.006

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  4 in total

1.  Anti-seizure medications for Lennox-Gastaut syndrome.

Authors:  Francesco Brigo; Katherine Jones; Christin Eltze; Sara Matricardi
Journal:  Cochrane Database Syst Rev       Date:  2021-04-07

Review 2.  Lennox-Gastaut Syndrome: In a Nutshell.

Authors:  Muhammad Umair Jahngir; Malik Qistas Ahmad; Memoona Jahangir
Journal:  Cureus       Date:  2018-08-13

3.  Treatment strategies for Lennox-Gastaut syndrome: outcomes of multimodal treatment approaches.

Authors:  Ji-Hoon Na; Da Eun Jung; Hee Jung Kang; Hoon-Chul Kang; Heung Dong Kim
Journal:  Ther Adv Neurol Disord       Date:  2022-08-03       Impact factor: 6.430

4.  GABAA receptor β3 subunit mutation D120N causes Lennox-Gastaut syndrome in knock-in mice.

Authors:  Shimian Qu; Mackenzie Catron; Chengwen Zhou; Vaishali Janve; Wangzhen Shen; Rachel K Howe; Robert L Macdonald
Journal:  Brain Commun       Date:  2020-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.